{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:10:47Z","timestamp":1790241047600,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","liver.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.cld.2015.08.013","type":"journal-article","created":{"date-parts":[[2015,10,21]],"date-time":"2015-10-21T07:27:53Z","timestamp":1445412473000},"page":"143-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Utility of Noninvasive Markers of Fibrosis in Cholestatic Liver Diseases"],"prefix":"10.1016","volume":"20","author":[{"given":"Christophe","family":"Corpechot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2015.08.013_bib1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0168-8278(00)80421-3","article-title":"Chronic cholestatic diseases","volume":"32","author":"Poupon","year":"2000","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2015.08.013_bib2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0168-8278(99)80098-1","article-title":"Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis","volume":"30","author":"Poupon","year":"1999","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2015.08.013_bib3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/gut.20.2.137","article-title":"Serum bilirubin: a prognostic factor in primary biliary cirrhosis","volume":"20","author":"Shapiro","year":"1979","journal-title":"Gut"},{"key":"10.1016\/j.cld.2015.08.013_bib4","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/0016-5085(87)90618-4","article-title":"Improved survival with primary sclerosing cholangitis. A review of clinicopathologic features and comparison of symptomatic and asymptomatic patients","volume":"92","author":"Helzberg","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2015.08.013_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198301063080101","article-title":"The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis","volume":"308","author":"Roll","year":"1983","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2015.08.013_bib6","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/hep.1840100406","article-title":"Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis","volume":"10","author":"Wiesner","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.08.013_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840100102","article-title":"Prognosis in primary biliary cirrhosis: model for decision making","volume":"10","author":"Dickson","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.08.013_bib8","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0025-6196(11)64614-4","article-title":"A\u00a0revised natural history model for primary sclerosing cholangitis","volume":"75","author":"Kim","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cld.2015.08.013_bib9","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22428","article-title":"Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis","volume":"48","author":"Corpechot","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.08.013_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2015.06.008","article-title":"Applicability and prognostic value of histologic scoring systems in primary sclerosing cholangitis","author":"de Vries","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2015.08.013_bib11","doi-asserted-by":"crossref","first-page":"S805","DOI":"10.1016\/S0168-8278(15)31394-5","article-title":"Histological stage is relevant for risk-stratification in primary biliary cirrhosis","volume":"62","author":"Carbone","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2015.08.013_bib12","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jhep.2015.02.023","article-title":"New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond","volume":"62","author":"Beuers","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2015.08.013_bib13","first-page":"387","article-title":"Primary biliary cirrhosis. Chronic non-suppurative destructive cholangitis","volume":"46","author":"Rubin","year":"1965","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cld.2015.08.013_bib14","first-page":"1257","article-title":"Primary biliary cirrhosis","volume":"60","author":"Scheuer","year":"1967","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.cld.2015.08.013_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00432479","article-title":"Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)","volume":"379","author":"Ludwig","year":"1978","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"10.1016\/j.cld.2015.08.013_bib16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1440-1827.2009.02500.x","article-title":"Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: Interobserver agreement","volume":"60","author":"Nakanuma","year":"2010","journal-title":"Pathol Int"},{"key":"10.1016\/j.cld.2015.08.013_bib17","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/liv.12620","article-title":"Primary biliary cirrhosis: proposal for a new simple histological scoring system","volume":"35","author":"Wendum","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2015.08.013_bib18","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.humpath.2012.09.017","article-title":"Evaluation of a new histologic staging and grading system for primary biliary cirrhosis in comparison with classical systems","volume":"44","author":"Kakuda","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.cld.2015.08.013_bib19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C. The METAVIR cooperative study group","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.08.013_bib20","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/gast.2002.31880","article-title":"Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients","volume":"122","author":"Corpechot","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2015.08.013_bib21","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/ajg.2010.216","article-title":"Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis","volume":"105","author":"Kumagi","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2015.08.013_bib22","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/hep.22517","article-title":"Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay","volume":"48","author":"Mayo","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.08.013_bib23","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/jcp.49.7.556","article-title":"Accuracy of staging in primary biliary cirrhosis","volume":"49","author":"Garrido","year":"1996","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.cld.2015.08.013_bib24","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/jcp.48.10.933","article-title":"Sampling variability of percutaneous liver biopsy in primary sclerosing cholangitis","volume":"48","author":"Olsson","year":"1995","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.cld.2015.08.013_bib25","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/hep.1840050420","article-title":"Increased serum levels of hyaluronate in liver disease","volume":"5","author":"Engstrom-Laurent","year":"1985","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.08.013_bib26","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1093\/clinchem\/37.10.1688","article-title":"Indocyanine green-sulfobromophthalein pharmacokinetics for diagnosing primary biliary cirrhosis and assessing histological severity","volume":"37","author":"Vaubourdolle","year":"1991","journal-title":"Clin Chem"},{"key":"10.1016\/j.cld.2015.08.013_bib27","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0140-6736(00)04258-6","article-title":"Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study","volume":"357","author":"Imbert-Bismut","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2015.08.013_bib28","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/hep.20935","article-title":"A\u00a0novel panel of blood markers to assess the degree of liver fibrosis","volume":"42","author":"Cales","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.08.013_bib29","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A\u00a0simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.08.013_bib30","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep.20506","article-title":"Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C","volume":"41","author":"Ziol","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.08.013_bib31","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/hep.21747","article-title":"Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C","volume":"46","author":"Lewin","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.08.013_bib32","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/hep.1840080127","article-title":"Serum hyaluronate in primary biliary cirrhosis\u2013a biochemical marker for progressive liver damage","volume":"8","author":"Nyberg","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.08.013_bib33","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/j.1440-1746.1996.tb00024.x","article-title":"Aminoterminal propeptide of type III procollagen and hyaluronan in patients with primary biliary cirrhosis: markers of fibrosis in primary biliary cirrhosis","volume":"11","author":"Remmel","year":"1996","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2015.08.013_bib34","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0168-8278(94)80013-8","article-title":"Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C","volume":"20","author":"Gu\u00e9chot","year":"1994","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2015.08.013_bib35","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/hep.25599","article-title":"Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis","volume":"56","author":"Corpechot","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.08.013_bib36","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1053\/j.gastro.2004.08.052","article-title":"Serum markers detect the presence of liver fibrosis: a cohort study","volume":"127","author":"Rosenberg","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2015.08.013_bib37","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ajg.2015.118","article-title":"Serum wisteria floribunda agglutinin-positive Mac-2-binding protein level predicts liver fibrosis and prognosis in primary biliary cirrhosis","volume":"110","author":"Umemura","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2015.08.013_bib38","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1478-3231.2004.0918.x","article-title":"Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis","volume":"24","author":"Corpechot","year":"2004","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2015.08.013_bib39","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1478-3231.2008.01722.x","article-title":"Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy","volume":"28","author":"Farkkila","year":"2008","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2015.08.013_bib40","first-page":"618","article-title":"A\u00a0noninvasive diagnostic model of liver fibrosis using serum markers in primary biliary cirrhosis","volume":"51","author":"Ma","year":"2012","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1016\/j.cld.2015.08.013_bib41","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.08.013_bib42","first-page":"887","article-title":"Performance and utility of transient elastography and noninvasive markers of liver fibrosis in primary biliary cirrhosis","volume":"43","author":"Floreani","year":"2011","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cld.2015.08.013_bib43","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1053\/j.gastro.2013.12.030","article-title":"Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis","volume":"146","author":"Corpechot","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2015.08.013_bib44","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1053\/j.gastro.2008.01.034","article-title":"Performance of transient elastography for the staging of liver fibrosis: a meta-analysis","volume":"134","author":"Friedrich-Rust","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2015.08.013_bib45","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/hep.23425","article-title":"Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations","volume":"51","author":"Castera","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.08.013_bib46","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2036.2007.03585.x","article-title":"Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis","volume":"27","author":"Gomez-Dominguez","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2015.08.013_bib47","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1055\/s-0034-1366057","article-title":"Liver stiffness assessed by acoustic radiation force impulse (ARFI) technology is considerably increased in patients with cholestasis","volume":"35","author":"Pfeifer","year":"2014","journal-title":"Ultraschall Med"},{"key":"10.1016\/j.cld.2015.08.013_bib48","doi-asserted-by":"crossref","first-page":"e0120110","DOI":"10.1371\/journal.pone.0120110","article-title":"The value of MRI in the diagnosis of primary biliary cirrhosis and assessment of liver fibrosis","volume":"10","author":"Meng","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cld.2015.08.013_bib49","doi-asserted-by":"crossref","DOI":"10.1111\/hepr.12470","article-title":"Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging as a useful detection method for advanced primary biliary cirrhosis","author":"Takeyama","year":"2015","journal-title":"Hepatol Res"},{"key":"10.1016\/j.cld.2015.08.013_bib50","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1177\/0284185112471792","article-title":"MR imaging of primary sclerosing cholangitis: additional value of diffusion-weighted imaging and ADC measurement","volume":"54","author":"Kovac","year":"2013","journal-title":"Acta Radiol"},{"key":"10.1016\/j.cld.2015.08.013_bib51","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/s00330-011-2296-y","article-title":"Integrative role of MRI in the evaluation of primary biliary cirrhosis","volume":"22","author":"Kovac","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1016\/j.cld.2015.08.013_bib52","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s00535-014-0946-y","article-title":"A\u00a0novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA(+)-M2BP), for assessing liver fibrosis","volume":"50","author":"Toshima","year":"2015","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.cld.2015.08.013_bib53","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1053\/j.gastro.2014.04.058","article-title":"Transient elastography in primary sclerosing cholangitis-the value as a prognostic factor and limitations","volume":"147","author":"Ehlken","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2015.08.013_bib54","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1002\/hep.22577","article-title":"Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis","volume":"48","author":"Millonig","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.08.013_bib55","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/hep.1840190314","article-title":"Predictive factors in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: role of serum markers of connective tissue","volume":"19","author":"Poupon","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.08.013_bib56","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/hep.27825","article-title":"Enhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis","volume":"62","author":"Vesterhus","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.08.013_bib57","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jhep.2014.01.029","article-title":"Optimising risk stratification in primary biliary cirrhosis: AST\/platelet ratio index predicts outcome independent of ursodeoxycholic acid response","volume":"60","author":"Trivedi","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2015.08.013_bib58","doi-asserted-by":"crossref","first-page":"e0131658","DOI":"10.1371\/journal.pone.0131658","article-title":"Serum cell death biomarkers for prediction of liver fibrosis and poor prognosis in primary biliary cirrhosis","volume":"10","author":"Sekiguchi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cld.2015.08.013_bib59","first-page":"336","article-title":"Nonsuppurative destructive chronic cholangitis and chronic hepatitis","volume":"3","author":"Popper","year":"1970","journal-title":"Prog Liver Dis"},{"key":"10.1016\/j.cld.2015.08.013_bib60","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2015.08.013_bib61","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3748\/wjg.15.591","article-title":"Biochemical markers for non-invasive assessment of disease stage in patients with primary biliary cirrhosis","volume":"15","author":"Alempijevic","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cld.2015.08.013_bib62","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/MCG.0b013e3181a84b8d","article-title":"Assessment of liver fibrosis and steatosis in PBC with FibroScan, MRI, MR-spectroscopy, and serum markers","volume":"44","author":"Friedrich-Rust","year":"2010","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cld.2015.08.013_bib63","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1478-3231.2006.01304.x","article-title":"The AST\/ALT ratio as an indicator of cirrhosis in patients with PBC","volume":"26","author":"Nyblom","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2015.08.013_bib64","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF02900712","article-title":"Biochemical markers of hepatic fibrosis in primary biliary cirrhosis","volume":"20","author":"Plebani","year":"1990","journal-title":"Ric Clin Lab"},{"key":"10.1016\/j.cld.2015.08.013_bib65","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1365-2796.1992.tb00964.x","article-title":"Serum hyaluronan and aminoterminal propeptide of type III procollagen in primary biliary cirrhosis: relation to clinical symptoms, liver histopathology and outcome","volume":"231","author":"Nyberg","year":"1992","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.cld.2015.08.013_bib66","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejim.2010.10.002","article-title":"Serum surrogate markers of liver fibrosis in primary biliary cirrhosis","volume":"22","author":"Voumvouraki","year":"2011","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.cld.2015.08.013_bib67","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(88)91843-0","article-title":"Type III procollagen peptide: a marker of disease activity and prognosis in primary biliary cirrhosis","volume":"1","author":"Babbs","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2015.08.013_bib68","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0168-8278(88)80047-3","article-title":"Serum basement membrane and type III procollagen-related antigens in primary biliary cirrhosis","volume":"6","author":"Niemela","year":"1988","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2015.08.013_bib69","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1471-230X-10-103","article-title":"Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis","volume":"10","author":"Friedrich-Rust","year":"2010","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.cld.2015.08.013_bib70","first-page":"797A","article-title":"Non-invasive assessment of liver fibrosis in primar y biliar y cirrhosis (PBC) patients using transient elastography by fibroscan, fibrotest (FT) and liver biopsy as reference method","volume":"58","author":"Munteanu","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.08.013_bib71","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0009-8981(88)90135-0","article-title":"Serum procollagen III N-terminal peptide and laminin P1 fragment concentrations in alcoholic liver disease and primary biliary cirrhosis","volume":"177","author":"van Zanten","year":"1988","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cld.2015.08.013_bib72","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1440-1746.1992.tb01492.x","article-title":"Clinical significance of the serum levels of the 7S domain of type IV collagen in patients with primary biliary cirrhosis","volume":"7","author":"Fukutomi","year":"1992","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2015.08.013_bib73","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.crad.2014.03.019","article-title":"Acoustic radiation force impulse elastography for non-invasive assessment of disease stage in patients with primary biliary cirrhosis: a preliminary study","volume":"69","author":"Zhang","year":"2014","journal-title":"Clin Radiol"},{"key":"10.1016\/j.cld.2015.08.013_bib74","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1478-3231.2007.01471.x","article-title":"High aspartate to alanine aminotransferase ratio is an indicator of cirrhosis and poor outcome in patients with primary sclerosing cholangitis","volume":"27","author":"Nyblom","year":"2007","journal-title":"Liver Int"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326115000859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326115000859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T02:49:51Z","timestamp":1748659791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326115000859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S1089326115000859"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2015.08.013","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility of Noninvasive Markers of Fibrosis in Cholestatic Liver Diseases","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2015.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}